Skip to main content
Pharmacognosy Magazine
An Open Access Journal in Pharmacognosy and Natural Products
Pharmacognosy Magazine

Main menu

  • Home
  • About Journal
  • Browse Issues
  • Author Guidelines & APC Information
  • Submit Article
  • Contact Us
Home /EGR1

EGR1

Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1

Liang X, Lan Z, Huang Y, Jiang G, Liu T. Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1. Pharmacognosy Magazine [Internet]. 2022;18(80):932-939. http://www.phcog.com/text.asp?2022/18/80/932/361754
  • Read more about Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1
  • Google Scholar
  • DOI
Subscribe to EGR1

Search

Articles from Phcog.Net Journals

About

Browse Online First Articles

Download Factsheet